Unseating big pharma: the radical plan for vaccine equity

Amy Maxmen

Nature, 2022, vol. 607, issue 7918, 226-233

Abstract: Charity failed to provide adequate vaccines for the global south. Now, 15 countries are seeing whether an open-science model can end a dangerous legacy of dependency.

Keywords: SARS-CoV-2; Biotechnology; Developing world; Intellectual-property rights (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/d41586-022-01898-3 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:607:y:2022:i:7918:d:10.1038_d41586-022-01898-3

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-022-01898-3

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().